Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Supernus Pharmaceuticals Inc (NASDAQ:SUPN)

17.80
Delayed Data
As of Aug 28
 +0.28 / +1.60%
Today’s Change
7.31
Today|||52-Week Range
23.30
+114.46%
Year-to-Date
No recent news for Supernus Pharmaceuticals Inc.

Today’s Trading

Previous close17.52
Today’s open17.49
Day’s range17.30 - 17.96
Volume681,158
Average volume (3 months)1,134,804
Market cap$862.3M
Dividend yield--
Data as of 3:59pm ET, 08/28/2015

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-52.08%
Earnings growth (next 5 years)+94.00%
Revenue growth (last year)+915.43%
P/E ratio27.2
Price/Sales3.44
Price/Book10.72

Competitors

 Today’s
change
Today’s
% change
ARRYArray Biopharma Inc+0.10+1.71%
FLMLFlamel Technologies ...-0.46-2.05%
SGYPSynergy Pharmaceutic...+0.01+0.14%
EPZMEpizyme Inc+2.60+14.86%
Data as of 4:14pm ET, 08/28/2015

Financials

Next reporting dateNovember 10, 2015
EPS forecast (this quarter)$0.03
Annual revenue (last year)$122.0M
Annual profit (last year)$19.9M
Net profit margin16.28%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, CEO, Director &
Secretary
Jack A. Khattar
CFO, Vice President &
Head-Investor Relations
Gregory S. Patrick
Corporate headquarters
Rockville, Maryland

Forecasts

Partner Offers